TOPIC

Biomedicine: Geopolitics

Related Topics:
Biomedicine: Geopolitics
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Healthcare and life sciences are the top growth prospects over the next three to five years, according to multinational corporations. Photo: Xinhua
Banking & finance

Global firms turn to M&A in EVs and biotech to deepen China investment: KPMG

Survey of multinational corporations finds optimism in life sciences, healthcare and manufacturing, with half forecasting revenue growth.

United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

China’s private sector

BeOne Medicines names R&D chief Wang Lai as president amid global expansion

Made in China 2025

Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion

Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.

A number of Chinese biotech firms have clinched licensing deals with multinational companies this year. Photo: Shutterstock
Science

China overtakes US in medical research in science power shift: top publisher

Country is ‘now global leader in scientific publishing and output’, Fred Fenter, chief executive editor of Swiss-based Frontiers, says.

videocam
30
China-Africa relations

China’s ‘health silk road’ in Africa gets a boost with insulin, pharma projects

Move to manufacture insulin locally is set against forecast of nearly 55 million Type 2 diabetes cases in sub-Saharan Africa by 2045.

videocam
Advertisement
Advertisement
Advertisement
China’s private sector

‘Quantity to quality’: what China’s next 5-year plan means for foreign investors

Beijing has pledged to open up even more to foreign investment. But some officials are becoming more selective about the projects they want.

videocam
Illustration: Brian Wang
Baidu

Baidu-backed drug discovery start-up Biomap challenges Google’s AlphaFold

Biomap expects to double its revenue this year, co-founder and CEO Wei Liu says.

Biomedicine: Companies

Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms

Chinese drug makers have ‘minimal sales exposure to the US’, Jefferies analysts say.

US-China relations

Opinion | Why US-China health and drugs cooperation must top Trump-Xi agenda

The years-long impasse harms both nations and the world, and the stakes in global health security could not be higher.

videocam
Illustration: Craig Stephens
US-China tech war

Chinese 3D biomolecule imaging start-up aims for IPO in 2027

Shuimu BioSciences is the first Chinese company to develop its own cryo-electron microscopy machine, a vital tool in drug discovery.

Allen Guo Chunlong, co-founder and CEO Shuimu BioSciences. Photo: Handout
Banking & finance

Global investment funds are tiptoeing into Hong Kong, aided by HKIC

“Geopolitics is not going away any time soon, but smart money needs to invest in the future,” the Hong Kong Investment Corporation’s CEO Clara Chan says.

China technology

China’s biotech industry is gaining on the US. Can tariffs hold them back?

Pharmaceutical firms in China have grown fast, but geopolitics and a long head start could keep US-based leaders at industry apex - for now.

videocam
US-China trade war

China, US end Stockholm trade talks, diverge on timing of tariff pause extension

After third round of negotiations, China signals consensus is reached while US team says no agreement until President Trump approves.

videocam
51
U.S. Treasury Secretary Scott Bessent attends a press conference about trade talks between China and the USA in Stockholm, Sweden, on Tuesday. Photo: TT News Agency via Reuters
Hong Kong economy

Opinion | How Hong Kong can lead in patient-focused ethical AI healthcare

AI can improve disease detection, surgery accuracy and data management but healthcare professionals can do a lot of good that AI cannot.

videocam
Illustration: Stephen Case
China manufacturing

China approving innovative drugs at record pace, shifting momentum from West

‘If we’re not careful, every drug could be made in China,’ warned former head of US Food and Drug Administration in May.

videocam
8
Science

China boosts Southeast Asian populations overlooked in Human Genome Project

Before China took a role in the research, fewer than 200 indigenous genomes from MSEA existed in global databases, according to Nature paper.

videocam
Advertisement
Advertisement
Advertisement
Artificial intelligence

XPrize founder Diamandis projects hope for AI, biotech amid US-China tech war

The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.

videocam
XPrize Foundation founder Peter Diamandis poses at the Four Seasons while attending the UBS Asia Investment Conference on May 28. Photo: Matt Haldane
Biomedicine: Companies

Chinese biotech firm secures Pfizer deal despite trade tensions

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.

videocam
Biomedicine: Companies

Chinese biotech giant sees strong US revenue despite trade tensions

The company, which has been targeted by Washington, saw US revenue jump 28 per cent in the first quarter, compared with 21 per cent globally.

Quantum computing

Chinese quantum computing firm tackles breast cancer screenings, drug design

Hefei-based Origin Quantum has demonstrated its computer’s ability to process medical imaging data ‘exponentially faster’ than classical machines.

Scientists work on the Origin Wukong superconducting quantum computer. Photo: Origin Quantum
Biomedicine: Companies

Hutchmed weighs cancer drug’s supply-chain options amid trade war

Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.

videocam
Hutchmed aims to expand Tazemetostat’s usage to patients with solid cancers. Photo: Shutterstock
New medical drugs

Trump’s tariffs: will Chinese pharmaceutical industry feel the pain?

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

videocam
6
Biomedicine: Companies

US report highlights China’s biotech rise, urges action to boost local industry

China is ‘quickly ascending to biotechnology dominance’ and the US must ‘take swift action in the next three years’, the report says.

4
US-China relations

US can keep edge over China aviation by staying integrated with it: expert

Testimony in advisory body hearing also heard stark warnings about China’s biotechnology advances.

videocam
A C919 passenger plane of China Commercial Aircraft Corporation performs a flight show at the Singapore Air Show in February 2024. Photo: Xinhua
Science

China’s first counter-sanction on US biotech industry a turning point in tech war

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive resolution’.

videocam
29
Leading American genomic sequencing firm Illumina is the first biotech company on China’s unreliable entity list. Photo: Shutterstock
Artificial intelligence

China’s tech push: Shanghai aims to be global medical AI hub by 2027

Despite US export curbs on advanced chips, China’s financial powerhouse is betting big on medical AI.

Science

China-born biologist Wang Cunyu returns from decades in US to head institute

Wang was recognised by Science magazine in 1996 for his work on cancer cell death.

videocam
43
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement